Prescription drug · ANDA
Meloxicam NDC 72189-684
Meloxicam 15 mg/1 · Tablet · Oral · Direct_Rx
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72189-684-30 | 72189068430 | 30 TABLET in 1 BOTTLE (72189-684-30)Marketed from Aug 12, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Meloxicam
- Generic name (nonproprietary)
- meloxicam
- Active ingredients
- Meloxicam — 15 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Direct_Rx
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 077882
- Marketing start
- Listing expires
- Other FDA classes
- Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
- Identifiers
- Product ID 72189-684_58dbce26-b2ad-2ce4-e063-6294a90a5727SPL ID 58dbce26-b2ad-2ce4-e063-6294a90a5727SPL set ID 58dbce26-b2ac-2ce4-e063-6294a90a5727RxCUI 152695UNII VG2QF83CGL
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472189068430followed by a unit qualifier and the quantityPackage 72189-0684-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
. 1.1 Osteoarthritis (OA) Meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [see Clinical Studies (14.1)] . 1.2 Rheumatoid Arthritis (RA) Meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [see Clinical Studies (14.1)] . 1.3 Juvenile Rheumatoid Arthritis (JRA) Pauciarticular and Polyarticular Course Meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course Juvenile Rheumatoid Arthritis in patients who weigh ≥60 kg [see Dosage and Administration (2.4)and Clinical Studies (14.2)] .
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 077882
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Bryant Ranch Prepack | 71335-3056 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Terrain Pharmaceuticals, Inc. | 53225-3015 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Terrain Pharmaceuticals, Inc. | 53225-3075 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Direct_Rx | 72189-683 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0558 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0563 |
| Meloxicam | Meloxicam 7.5 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0559 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0585 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0584 |
| Meloxicam | Meloxicam 15 mg/1 | TabletOral | Advanced Rx of Tennessee, LLC | 80425-0586 |